Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacodynamic Models: Overview01:27

Pharmacodynamic Models: Overview

Pharmacodynamic (PD) responses describe the interaction between a drug and its biological target, culminating in a physiological effect. These responses can be classified into different types: continuous variables, such as blood glucose levels; categorical outcomes, like survival rates; and time-to-event metrics, such as disease progression. Understanding and modeling PD responses are critical for optimizing drug efficacy and safety.PD models describe the relationship between drug concentration...
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Methods of Documentation VI: Case Management Model01:15

Methods of Documentation VI: Case Management Model

The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic illness...
Pharmacokinetic Models: Overview01:20

Pharmacokinetic Models: Overview

Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal assumptions,...
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Physiological Pharmacokinetic Models: Blood Flow-Limited Versus Diffusion-Limited Models00:57

Physiological Pharmacokinetic Models: Blood Flow-Limited Versus Diffusion-Limited Models

Physiological pharmacokinetic models, often called flow-limited or perfusion models, typically assume a swift drug distribution between tissue and venous blood, creating a rapid drug equilibrium. This premise is based on the idea that drug diffusion is extremely fast, and the cell membrane presents no barrier to drug permeation. In this scenario, where no drug binding occurs, the drug concentration in the tissue equals that of the venous blood leaving the tissue. This greatly simplifies the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Liquidity shock mitigation and mental health: Evidence from pension withdrawals during the COVID-19 pandemic in Chile.

Social science & medicine (1982)ยท2026
Same author

Using Under-Represented Subgroup Fine Tuning to Improve Fairness for Disease Prediction.

Biomedical engineering systems and technologies, international joint conference, BIOSTEC ... revised selected papers. BIOSTEC (Conference)ยท2025
Same author

The financial consequences of undiagnosed memory disorders.

Journal of financial economicsยท2025
Same author

Claim Denials for Cancer-Related Next-Generation Sequencing in Medicare.

JAMA network openยท2025
Same author

Scenarios, not shortage forecasts, are key to better workforce policy.

Health affairs scholarยท2024
Same author

The effect of stand-your-ground laws on student achievement.

Preventive medicine reportsยท2024

Related Experiment Video

Updated: May 14, 2026

Using Simulation Models to Train Clinicians in the Use of Point-of-Care Ultrasound
05:04

Using Simulation Models to Train Clinicians in the Use of Point-of-Care Ultrasound

Published on: August 9, 2024

Opportunities and challenges in supply-side simulation: physician-based models.

Carole Roan Gresenz1, David I Auerbach, Fabian Duarte

  • 1Department of Health Systems Administration, Georgetown University, Washington, DC, USA.

Health Services Research
|January 26, 2013
PubMed
Summary

Developing supply-side microsimulation models for healthcare requires integrating diverse data sources. Current data limitations highlight the need for novel collection methods to advance health policy simulation.

More Related Videos

Model Surgical Training: Skills Acquisition in Fetoscopic Laser Photocoagulation of Monochorionic Diamniotic Twin Placenta Using Realistic Simulators
09:51

Model Surgical Training: Skills Acquisition in Fetoscopic Laser Photocoagulation of Monochorionic Diamniotic Twin Placenta Using Realistic Simulators

Published on: March 21, 2018

Related Experiment Videos

Last Updated: May 14, 2026

Using Simulation Models to Train Clinicians in the Use of Point-of-Care Ultrasound
05:04

Using Simulation Models to Train Clinicians in the Use of Point-of-Care Ultrasound

Published on: August 9, 2024

Model Surgical Training: Skills Acquisition in Fetoscopic Laser Photocoagulation of Monochorionic Diamniotic Twin Placenta Using Realistic Simulators
09:51

Model Surgical Training: Skills Acquisition in Fetoscopic Laser Photocoagulation of Monochorionic Diamniotic Twin Placenta Using Realistic Simulators

Published on: March 21, 2018

Area of Science:

  • Health economics
  • Health services research
  • Computational modeling

Background:

  • Microsimulation models are crucial for health policy analysis.
  • Supply-side factors significantly influence healthcare markets.
  • Existing models often lack comprehensive data on healthcare supply-side dynamics.

Purpose of the Study:

  • To establish a conceptual framework for supply-side microsimulation modeling in healthcare.
  • To evaluate the availability and suitability of empirical data for such models.
  • To identify data gaps and future data collection needs.

Main Methods:

  • Developed a conceptual framework for supply-side microsimulation.
  • Assessed data availability using multiple secondary sources (e.g., American Community Survey, Health Tracking Physician Survey).
  • Applied the framework to physician data to evaluate its adequacy for simulation.

Main Results:

  • The conceptual framework identifies three key data types for supply-side microsimulation.
  • Physician data show some comparability across sources but require significant integration.
  • Limited data exist for complex organizational and financial relationships among supply-side entities.
  • A growing body of literature offers potential behavioral parameters for model engines.

Conclusions:

  • Integrating diverse data sources is a primary challenge for effective supply-side microsimulation.
  • Novel data collection strategies are needed to enhance future simulation models.
  • Improved data and models can significantly inform health policy decisions.